Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances
CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)
DOI: 10.1002/cns.71109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 25.08.2026. Verfasst von Jiayan Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Central Nervous System Diseases, Lipid Metabolism. Die Arbeit nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Lipids are fundamental components of the central nervous system (CNS) structure and are essential for maintaining physiological homeostasis. Dysregulation of lipid homeostasis is a critical mechanism driving the pathogenesis and progression of classic CNS diseases, including neurodegenerative disorders, traumatic injuries, and cerebrovascular diseases. These metabolic disturbances trigger pathological processes such as abnormal protein aggregation, neuroinflammation, and lipid peroxidation, creating a vicious cycle that exacerbates disease progression. While targeting lipid metabolism offers a novel therapeutic strategy, its clinical translation faces significant hurdles. Scope of Review This review systematically summarizes the pathological roles and molecular mechanisms of lipid metabolism dysregulation across six representative CNS disorders: Alzheimer's disease (AD), Parkinson's disease (PD), spinal cord injury (SCI), traumatic brain injury (TBI), stroke, and intracerebral hemorrhage (ICH). These conditions were selected to cover a spectrum of pathologies, including protein‐aggregation neurodegeneration, posttraumatic secondary injury, and cerebrovascular damage. The article outlines recent advances in therapeutic interventions targeting lipid metabolism and dissects both the shared and disease‐specific regulatory mechanisms within the CNS. Key Challenges Despite the therapeutic potential, several challenges impede the development of effective lipid‐targeting treatments. These include the incompletely defined mechanisms underlying dynamic lipid changes across different disease stages, insufficient efficiency of drug delivery across the blood–brain barrier, and the limited efficacy of single‐target interventions. This review addresses these existing hurdles and proposes potential solutions to overcome them.
Conclusion
Targeting lipid metabolism represents a promising frontier for treating CNS diseases. By providing a comprehensive reference on the metabolic underpinnings of these disorders and addressing current research bottlenecks, this review aims to lay the groundwork for the development of precise, targeted therapeutic strategies in future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- Department of Orthopedics, Changzheng Hospital, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.
- Department of Stress Medicine, Faculty of Psychology, Naval Medical University, Shanghai, China.
- Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Jiayan Yuan, Shixue Huang, Kun Jiao, Wei Wang, Haoming Shu, Xuhui Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yuan, J., Huang, S., Jiao, K., Yang, S., Ge, X., Liu, W., Wang, W., Shu, H., & Zhou, X. (2026). Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71109
Vancouver
Yuan J, Huang S, Jiao K, Yang S, Ge X, Liu W, et al. Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71109
BibTeX
@article{Yuan2026,
author = {Yuan, Jiayan and Huang, Shixue and Jiao, Kun and Yang, Shu and Ge, Xuhui and Liu, Wei and Wang, Wei and Shu, Haoming and Zhou, Xuhui},
title = {Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/cns.71109}
}
EUVIMED